BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 38542126)

  • 1. Research Progress on Lipophagy-Mediated Exercise Intervention in Non-Alcoholic Fatty Liver Disease.
    Li X; Yang Y; Sun Y; Ding S
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophagy: A potential therapeutic target for nonalcoholic and alcoholic fatty liver disease.
    Han YH; He XM; Jin MH; Sun HN; Kwon T
    Biochem Biophys Res Commun; 2023 Sep; 672():36-44. PubMed ID: 37336123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Lipophagy and Chaperone-Mediated Autophagy in the Pathogenesis of Non-Alcoholic Fatty Liver Disease by Regulation of Lipid Droplets.
    Mastoridou EM; Goussia AC; Kanavaros P; Charchanti AV
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy.
    Gao Y; Zhang W; Zeng LQ; Bai H; Li J; Zhou J; Zhou GY; Fang CW; Wang F; Qin XJ
    Redox Biol; 2020 Sep; 36():101635. PubMed ID: 32863214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise ameliorates lipid droplet metabolism disorder by the PLIN2-LIPA axis-mediated lipophagy in mouse model of non-alcoholic fatty liver disease.
    Fang C; Liu S; Yang W; Zheng G; Zhou F; Gao X; Qin L; Yang G; Yang J; Zhu G; Wang X; Huang K; Yang X; Wei Y; Peng S; Li L
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167045. PubMed ID: 38306800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging role of lipophagy in liver disorders.
    Nazeer B; Khawar MB; Khalid MU; Hamid SE; Rafiq M; Abbasi MH; Sheikh N; Ali A; Fatima H; Ahmad S
    Mol Cell Biochem; 2024 Jan; 479(1):1-11. PubMed ID: 36943663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderate Treadmill Exercise Alleviates NAFLD by Regulating the Biogenesis and Autophagy of Lipid Droplet.
    Yang Y; Li X; Liu Z; Ruan X; Wang H; Zhang Q; Cao L; Song L; Chen Y; Sun Y
    Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipophagy mediated carbohydrate-induced changes of lipid metabolism via oxidative stress, endoplasmic reticulum (ER) stress and ChREBP/PPARγ pathways.
    Zhao T; Wu K; Hogstrand C; Xu YH; Chen GH; Wei CC; Luo Z
    Cell Mol Life Sci; 2020 May; 77(10):1987-2003. PubMed ID: 31392349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise improves lipid droplet metabolism disorder through activation of AMPK-mediated lipophagy in NAFLD.
    Li H; Dun Y; Zhang W; You B; Liu Y; Fu S; Qiu L; Cheng J; Ripley-Gonzalez JW; Liu S
    Life Sci; 2021 May; 273():119314. PubMed ID: 33667513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipophagy and liver disease: New perspectives to better understanding and therapy.
    Zhang Z; Yao Z; Chen Y; Qian L; Jiang S; Zhou J; Shao J; Chen A; Zhang F; Zheng S
    Biomed Pharmacother; 2018 Jan; 97():339-348. PubMed ID: 29091883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease.
    Zhang Y; Chen Y
    Chin Med J (Engl); 2022 Jul; 135(14):1673-1681. PubMed ID: 35950774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease.
    Grefhorst A; van de Peppel IP; Larsen LE; Jonker JW; Holleboom AG
    Front Endocrinol (Lausanne); 2020; 11():601627. PubMed ID: 33597924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naringin Protects against Non-Alcoholic Fatty Liver Disease by Promoting Autophagic Flux and Lipophagy.
    Guan L; Guo L; Zhang H; Liu H; Zhou W; Zhai Y; Yan X; Men X; Peng L
    Mol Nutr Food Res; 2024 Feb; 68(3):e2200812. PubMed ID: 38054638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ménage à trois of autophagy, lipid droplets and liver disease.
    Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
    Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Two-Photon Imaging Analysis of Dynamic Degradation of Hepatic Lipid Droplets in MS-275-Treated Mouse Liver.
    Lee CG; Lee SJ; Park S; Choi SE; Song MW; Lee HW; Kim HJ; Kang Y; Lee KW; Kim HM; Kwak JY; Lee IJ; Jeon JY
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease.
    Zhang H; Lu J; Liu H; Guan L; Xu S; Wang Z; Qiu Y; Liu H; Peng L; Men X
    Pharmacol Res; 2021 Dec; 174():105964. PubMed ID: 34732369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy and Lipid Droplets in the Liver.
    Martinez-Lopez N; Singh R
    Annu Rev Nutr; 2015; 35():215-37. PubMed ID: 26076903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver disease.
    Du J; Ji X; Xu B; Du Q; Li Y; Zhou B; Liu X; Xu Z; Jiang Y; Kou B; Li Z; Cui C; Lin J
    Metabolism; 2024 Mar; 152():155769. PubMed ID: 38158076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting lipophagy as a potential therapeutic strategy for nonalcoholic fatty liver disease.
    Li HY; Peng ZG
    Biochem Pharmacol; 2022 Mar; 197():114933. PubMed ID: 35093393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD.
    Mashek DG
    Mol Metab; 2021 Aug; 50():101115. PubMed ID: 33186758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.